Get started
Work

Supplementary Table 1 from Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 1 shows the p53 mutation in the PDX models
DOI: 10.1158/1535-7163.22505619.v1
Authors: Claudia Iavarone, Ioannis K. Zervantonakis, Laura M. Selfors, Sangeetha Palakurthi, Joyce F. Liu, Ronny Drapkin, Ursula A. Matulonis, Dorothy Hallberg, Victor E. Velculescu, Joel D. Leverson, Deepak Sampath, Gordon B. Mills, Joan S. Brugge
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362622907
Cites:
Cited by:
Related to: 10